Denali Therapeutics Inc (DNLI)
Financing Cash Flow
$14.98M
Quarterly · Period ending: · USD
DNLI Financing Cash Flow
Latest reported$14.98Mperiod ending
Latest reported$14.98Mperiod ending
DNLI Quarterly Cash from Financing ($146.39M → $14.98M)
Quarterly financing cash flow
High-resolution chart · PNG
DNLI financing cash flow history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Financing Cash Flow (USD) |
|---|---|
| 14,984,000 | |
| 219,044,000 | |
| 192,133,000 | |
| -778,000 | |
| 1,623,000 | |
| -3,762,000 | |
| -4,168,000 | |
| -18,559,000 | |
| 6,756,000 | |
| 500,275,000 | |
| 4,705,000 | |
| 2,492,000 | |
| 9,019,000 | |
| 1,604,000 | |
| 299,651,000 | |
| 5,154,000 | |
| 4,402,000 | |
| 1,463,000 | |
| 5,168,000 | |
| 3,315,000 | |
| 7,043,000 | |
| 3,822,000 | |
| 9,522,000 | |
| 425,899,000 | |
| 3,415,000 | |
| 195,913,000 | |
| 2,033,999 | |
| 679,000 | |
| 2,569,000 | |
| 908,000 | |
| 1,690,000 | |
| 658,000 | |
| 1,432,000 | |
| 93,239,000 | |
| 295,591,000 | |
| 357,000 | |
| 51,000 | |
| 324,000 | |
| -4,000 | |
| 7,694,000 | |
| 146,393,000 | |
| 146,393,000 |